J. Goldman & Co’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

J. Goldman & Co’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,962	Closed	-$565K	–	670
2024 Q3	$565K	Sell	16,962 -8,707	-34%	-$300K	0.02%	339
2024 Q2	$694K	Sell	25,669 -89,811	-78%	-$1.77M	0.02%	338
2024 Q1	$2.49M	Buy	+115,480	New	+$2.52M	0.08%	204

J. Goldman & Co's LBPH Position: Q4 2024 in Review

J. Goldman & Co sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 16,962 shares — an estimated $565K sold.

J. Goldman & Co first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $2.49M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

J. Goldman & Co reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
J. Goldman & Co sold 16,962 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $565K.
J. Goldman & Co first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
J. Goldman & Co's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $2.49M in Q1 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.